METRO HEALTHCARE BERHAD

KLSE: 0329 (METRO)

Last update: 1 hour ago

0.205

0.00 (2.50%)

Previous Close 0.200
Open 0.200
Volume 394,900
Avg. Volume (3M) 492,708
Market Cap 200,675,536
Price / Earnings (TTM) 20.50
Price / Earnings (Forward) 36.63
Price / Sales 3.88
Price / Book 2.61
52 Weeks Range
0.190 (-7%) — 0.245 (19%)
TTM Dividend Yield 2.44%
Profit Margin 6.52%
Operating Margin (TTM) 7.02%
Quarterly Revenue Growth (YOY) -9.20%
Quarterly Earnings Growth (YOY) -82.70%
Total Debt/Equity (MRQ) 20.42%
Current Ratio (MRQ) 10.75
Operating Cash Flow (TTM) 6.88 M
Levered Free Cash Flow (TTM) 4.15 M
Return on Assets (TTM) 6.31%
Return on Equity (TTM) 5.47%

Market Trend

Short Term Medium Term
Industry Medical Care Facilities (MY) Mixed Mixed
Medical Care Facilities (Global) Bullish Bullish
Stock METRO - -

AIStockmoo Score

0.5
Analyst Consensus 0.0
Insider Activity 0.0
Price Volatility 0.5
Technical Moving Averages 2.5
Technical Oscillators -0.5
Average 0.50

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
METRO 201 M 2.44% 20.50 2.61
ALPHA 1 B 3.77% 26.50 6.40
TOPVISN 48 M 12.90% 15.50 1.09
SUNMED 22 B - 96.50 8.59
IHH 78 B 1.20% 36.58 2.55
KPJ 15 B 1.34% 41.25 5.22

Metro Healthcare Bhd is engaged in the provision of women healthcare services. The company offers various services such as obstetrics, gynecology impatient services, and diagnostic medical imaging services. It also provides semen analysis, intracytoplasmic sperm injection, blastocyst culture, assisted hatching, frozen embryo transfer, preimplantation genetic screening, and infertility consultation services. The company serves patients in Malaysia.

Sector Healthcare
Industry Medical Care Facilities
Investment Style Small Growth
% Held by Insiders 69.24%
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
MR LIM WAI KHONG 0.210 - 98,000 20,580
ENCIK SHEIKH MOHD NASARUDIN - 0.205 -2,098,800 -430,254
Aggregate Net Quantity -2,000,800
Aggregate Net Value ($) -409,674
Aggregate Avg. Buy ($) 0.210
Aggregate Avg. Sell ($) 0.205
Name Holder Date Type Quantity Price Value ($)
MR LIM WAI KHONG Director 16 Apr 2026 Acquired (+) 98,000 0.210 20,580
ENCIK SHEIKH MOHD NASARUDIN Substantial Shareholder 10 Apr 2026 Disposed (-) 999,500 0.205 204,898
ENCIK SHEIKH MOHD NASARUDIN Substantial Shareholder 08 Apr 2026 Disposed (-) 1,099,300 0.205 225,357
Date Type Details
17 Apr 2026 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
17 Apr 2026 Announcement Changes in Director's Interest (Section 219 of CA 2016) - MR LIM WAI KHONG
14 Apr 2026 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - ENCIK SHEIKH MOHD NASARUDIN
13 Apr 2026 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
10 Apr 2026 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - ENCIK SHEIKH MOHD NASARUDIN
03 Apr 2026 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - ENCIK SHEIKH MOHD NASARUDIN
31 Mar 2026 TheEdge Sunway Healthcare’s IPO ignites healthcare stock frenzy
30 Mar 2026 Announcement PUBLIC SHAREHOLDINGS SPREAD
26 Mar 2026 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
26 Mar 2026 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR TAY SWI PENG @ TEE SWI PENG
26 Mar 2026 Announcement Changes in Director's Interest (Section 219 of CA 2016) - DR TAY SWI PENG @ TEE SWI PENG
25 Mar 2026 Announcement PUBLIC SHAREHOLDINGS SPREAD
20 Mar 2026 Announcement METRO - Notice of Book Closure
19 Mar 2026 Announcement Interim Dividend
13 Mar 2026 Announcement Changes in Director's Interest (Section 219 of CA 2016) - MR LIM WAI KHONG
13 Mar 2026 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
10 Mar 2026 Announcement TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : RELATED PARTY TRANSACTIONS
27 Feb 2026 Announcement PUBLIC SHAREHOLDINGS SPREAD
24 Feb 2026 Announcement Quarterly rpt on consolidated results for the financial period ended 31/12/2025
10 Feb 2026 TheEdge Alpha IVF says worst of start-up pains is over, still eyes regional expansion
04 Feb 2026 Announcement TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : RELATED PARTY TRANSACTIONS
04 Feb 2026 Announcement General Meetings: Outcome of Meeting
21 Jan 2026 Announcement TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : RELATED PARTY TRANSACTIONS
Show more
TTM Dividend Yield 2.44%
1Y Average Dividend Yield 2.96%
Payout Ratio 114.89%
Expected Next Dividend Payment Oct 2026
Ex Date Announcement Date Payment Date Details
06 Apr 2026 19 Mar 2026 17 Apr 2026 0.0025 Cash
03 Oct 2025 19 Sep 2025 16 Oct 2025 0.0025 Cash
10 Apr 2025 21 Mar 2025 22 Apr 2025 0.004 Cash

Annual Dividend Yield

Year Annual Dividend ($) Frequency/Year Yield %
2026 0.003 1 1.22
2025 0.007 2 2.96

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria